GlaxoSmithkline Consumer Healthcare (Delisted) share news and announcements

BSE: 500676

Formerly Smithkline Beecham Consumer Healthcare

Last traded ₹10,732.60 on 15 Apr 2020

Delisted on 24 Jun 2021.

GlaxoSmithkline Consumer Healthcare share news and announcements

668 announcements, routine notices left out, newest first. Page 4 of 14.

Oct 2018
- 15 Oct · Analysts
  Analysts/Institutional Investor Meet/Con. Call UpdatesDear Sir / Madam,In reference to our intimation dated August 09, 2018 w.r.t. Schedule of Analyst, we wish to inform you that intimation was filed in time but was inadvertently given in the wrong letter head.The details of Analyst / Institutional Investors Meeting held on Thursday, August 9, 2018 is as follows: Type of Meeting Time of Event Dial - in DetailsConference Call 1100 hours (IST) India +91 22 6280 1145/ +91 22 7115 8046 Hong Kong 800 964 448 Singapore 800 101 2045 UK 0 808 101 1573 USA 1 866 746 2133Request you to please take the above information on record and ignore the earlier intimation. (opens in a new tab)
- 15 Oct · Analysts
  Dear Sir / Madam, In reference to our intimation dated August 09, 2018 w.r.t. Schedule of Analyst, we wish to inform you that intimation was filed in time but was inadvertently .... (opens in a new tab)
- 9 Oct · Shareholding for the Period Ended September 30, 2018
  Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click ....
- 9 Oct · Certificate Under Regulation 40 (9) Of SEBI (LODR) Regulations 2015
  In compliance with the Regulation 40(9) & 40(10) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, please find attached herewith the certificate from Mr. S. Anand .... (opens in a new tab)
- 9 Oct · Compliance Certificate Under Regulation 7 (3) Of SEBI (LODR) Regulations, 2015
  We are enclosing herewith Compliance Certificate for the half year ended September 30, 2018. .... (opens in a new tab)
- 9 Oct · Statement Of Investor Complaints For The Quarter Ended September 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 14 14 <td class='TTRow'
Sep 2018
- 25 Sep · Management
  Change in Director(s) of the company. (opens in a new tab)
- 25 Sep · Management
  We wish to inform you that the Board of Directors through a circulation resolution .... (opens in a new tab)
- 11 Sep · Analysts
  We would wish to inform you that the Senior Management of the Company will be participating .... (opens in a new tab)
- 11 Sep · Analysts
  Analysts/Institutional Investor Meet/Con. Call Updates (opens in a new tab)
Aug 2018
Jul 2018
- 23 Jul · Dividend
  This is to inform you that pursuant to the provisions of Section 91 of the Companies Act, 2013, and Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, .... (opens in a new tab)
- 23 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2018 (opens in a new tab)
- 23 Jul · Board Meeting Dated 07/08/2018
  Notice is hereby given that a meeting of the Board of Directors of the Company will .... (opens in a new tab)
- 11 Jul · Shareholding for the Period Ended June 30, 2018
  Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....
- 9 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 19 19 <td class='TTRow'
Jun 2018
- 30 Jun · Management
  Change in Director(s) of the company. (opens in a new tab)
- 30 Jun · Management
  We would like to inform you that 'Horlicks Limited' has nominated Mr. Patnam Dwarakanath as Nominee Director and Non-Executive Chairman of the Company with effect from July 1, 2018. .... (opens in a new tab)
- 26 Jun · Clarifies on News item
  With reference to news appeared on The Economic Times dated June 26, 2018 quoting "Coca-Cola plans to boost muscle with Horlicks buy.", GlaxoSmithkline Consumer Healthcare Ltd has submitted .... (opens in a new tab)
- 26 Jun · News Verification
  Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned "Coca Cola plans to boost muscle with Horlicks buy". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. GlaxoSmithKline Consumer Healthcare Limited has submitted their response. (opens in a new tab)
- 26 Jun · News Verification
  Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned Coca Cola plans to boost muscle with Horlicks buy. In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
- 26 Jun · Legal
  Exchange has sought clarification from GlaxoSmithkline Consumer Healthcare Ltd on June 26, 2018, with reference to news appeared on The Economic Times dated June 26, 2018 quoting "Coca-Cola ....
- 25 Jun · Management
  Change in Director(s) of the company. (opens in a new tab)
- 25 Jun · Management
  This is to inform you that the Company has received a letter from Horlicks Limited that it has withdrawn the Nomination of Mr. Joaquin Beneyto Mascaro, as the Director of the Company with .... (opens in a new tab)
May 2018
- 14 May · Results
  Financial results for the period ended March 31, 2018. (opens in a new tab)
- 12 May · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from August 02, 2018 to August 08, 2018 (both .... (opens in a new tab)
- 11 May · Dividend
  Board of Directors of the Company at its meeting held on May 11, 2018 the Board also recommended a Dividend at the rate of Rs. 75/-per equity share of Rs. 10 each. (opens in a new tab)
- 11 May · Meeting
  Register of Members and Share Transfer Books of the Company shall remain closed from August 2, 2018 to August 8, 2018(both days inclusive) for the purpose of dividend and Annual General Meeting of the Company is scheduled to be held on August 08, 2018. (opens in a new tab)
- 11 May · Dividend
  Date of payment of dividend (opens in a new tab)
- 11 May · Amendment to AOA/MOA
  Amendment to AOA/MOA of the company. (opens in a new tab)
- 11 May · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
  Board has approved subject to approval of the Shareholders at the ensuing Annual General Meeting the amendment of the Articles of Association of the Company. (opens in a new tab)
- 11 May · Dividend
  Board recommended a Dividend at the rate of Rs. 75/- per equity share of Rs. 10 each. The Dividend, if approved by the shareholders in the ensuing Annual General Meeting scheduled to .... (opens in a new tab)
- 11 May · Board meeting
  Board meeting held on May 11, 2018. (opens in a new tab)
- 11 May · Meeting
  Board of Directors of the Company at its meeting held on May 11, 2018, inter alia, has recommended a Dividend at the rate .... (opens in a new tab)
- 11 May · Disclosure
  Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 11 May · Results
  In accordance with SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, please note that the Board of Directors of the Company at its meeting held on May 11, 2018, has .... (opens in a new tab)
- 9 May · Analysts
  Analysts/Institutional Investor Meet/Con. Call Updates (opens in a new tab)
- 9 May · Analysts
  Analyst / Institutional Investors Meeting to be held on Friday, May 11, 2018. (opens in a new tab)
- 3 May · Results
  Please note that a meeting of the Board of Directors of the Company will be held on Friday, May 11, 2018 at 01:00 p.m. at the Corporate Office of the Company situated at 24th & 25th Floor, .... (opens in a new tab)
- 3 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2018, dividend and other business matters (opens in a new tab)